Journal of Clinical Microbiology, May 1997, 1045-1048, Vol 35, No. 5
A Sjostedt, U Eriksson, L Berglund and A Tarnvik
The diagnosis of human cases of tularemia is usually confirmed by the
demonstration of an antibody response to Francisella tularensis, which
occurs about 2 weeks after the onset of disease. Due to a high risk of
infection in the laboratory, cultivation of the causative agent tends to be
avoided. During an outbreak in Sweden, the use of PCR for diagnosing the
ulceroglandular form of tularemia was evaluated. Extraction and preparation
of F. tularensis DNA from swab samples from the wounds of patients with
tularemia involved the use of the nuclease inhibitor guanidine thiocyanate.
The DNA was detected by multiplex PCR targeting the 16S rRNA gene and a
17-kDa lipoprotein gene of F. tularensis. In 29 of 40 (73%) patients with
serologically confirmed tularemia, F. tularensis DNA was successfully
amplified. Considering the limitations of current diagnostic procedures,
PCR may become useful for the early diagnosis of tularemia.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Detection of Francisella tularensis in ulcers of patients with tularemia by PCR
Department of Microbiology, National Defence Research Establishment, Umea, Sweden. sjostedt@ume.foa.se
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|